Guest Editorial
Diagnostic testing remains a vital component of clinical medicine. It is a rapidly expanding field limited only by managerial accountability for expenditure and inevitable cost constraints. The practical imperative is to do more with less money and to do it more rapidly than hitherto. The needs and expectations of a modern informed society intensify demands for re-thinking the way things are done [1] . To achieve this, the laboratory professions must be aware of the valuable opportunities and cost-effective alternatives which exist. To be economically competitive not only must the best medical scientific solutions be planned and implemented but also their operational efficiency must be assured. Integrated healthcare systems involve automated analysis, robotic workstations and a continuum of data communication which extends to the point of care. Since technical developments in laboratory medicine are occurring at an alarming rate, it is difficult for the practising laboratorian to keep abreast of current innovation. For this reason symposia describing recent advances and their evaluation serve a useful purpose. The proceedings of the symposium published in this present issue of INFUSION THERAPY AND TRANSFUSION MEDICINE is no exception, covering evaluation reports of novel automated parameters of the blood count presented by acknowledged experts in the field, and reviews of imminent developments in information technology and communication, all designed to improve the efficiency of laboratory practice and to impact at the laboratory/clinician interface. The assessment of erythropoietic function using automated blood cell counters is fundamental to the diagnosis and follow-up of patients with anaemia. In recent years there has occurred a progression from a first-line classification using mean cellular volume (MCV) and red blood cell distribution width (RDW) to a more dynamic approach using, in addition, the total reticulocyte count and the immature reticulocyte fraction (IRF) [2] and more recently the nucleated red blood cell count (NRBC) count. Professor Guiseppe d'Onofrio from Universita Cattolica, Rome, presents evaluation data on the NRBC count produced by the Sysmex XE-2100 and reviews the overall clinical utility of NRBC and reticulocyte counting. A multi-dimensional approach involving red blood cells, reticulocytes, IRF and NRBC is presented. Using this approach 'added clinical diagnostic value' clearly results. Peripheral blood stem cells are increasingly used to restore haematopoiesis following myeloablative therapy in patients with haematological malignancies or solid tumours.. As the engraftment and reconstitution of bone marrow function is dependent on the transfusion of sufficient stem cells, an adequate and reliable analytical method for their precise enumeration is mandatory. Hitherto the parameter most widely used is the CD34+ cell count by immunological methods. This is time-consuming, costly and requires expertise hence alternative approaches are desirable. The Sysmex SE-9500 and XE-2100 blood cell analysers provide a gate in the immature myeloid information (IMI) channel within which stem cells (haematopoietic progenitor cells (HPC) [3] ) are reported to lie. Two studies of this parameter are reported in this issue but from very different populations. The first is by Dr. Kai Gutensohn from the University Hospital Hamburg-Eppendorf, Germany, who, in his study of adult patients with acute leukaemia, non-Hodgkin's lymphoma and solid tumours, concluded that HPC counts, using this technology, may be useful as a trigger parameter to determine the onset of flow-cytometric analyses although inter-individual and inter-disease differences may occur. It is his opinion that the predictive value of HPC counts for monitoring graft quality is low. The second paper is by Professor Donna Wall of the St Louis Cord Blood Bank, MO, USA. Here it is reported from a prospective series of children undergoing stem cell apheresis after chemotherapy/ growth factor mobilisation that the peripheral blood HPC measurement on the day of planned apheresis correlates well with CD34 assessment and the ability to collect an adequate stem cell product. Additionally, the HPC measurement after 2 blood volume collections accurately predicts final collection yields. The HPC measurement is especially useful in paediatrics where the children tend to demonstrate a robust mobilisation. Clearly further studies are necessary to determine the effect of disease and its pre-treatment on HPC counts. The identification of NRBC apart from small mature lymphocytes has long posed a problem in automated blood cell counting. The alternative has been microscopy but this is time-consuming, and very low concentrations of NRBC are difficult to detect (<200/µl). Yet the presence of circulating NRBC is clinically significant in neonates while in adults their existence usually indicates serious disease. Dr. Axel Stachon from the Ruhr-University of Bochum, Germany, describes a study using microscopy to analyse the prognostic significance of circulating NRBC in a large cohort of patients undergoing cardiothoracic surgery. This study reveals that the post-operative detection of NRBC indicates a poor prognosis. It has been extended to over 15,000 patients from general and accident surgery, cardiothoracic surgery, neurology and internal medicine (without haematology patients). Measurements were made by an automated haematology analyzer. The mortality rate of patients with NRBC was 21.1%, whereas for those without NRBC the rate was 1.2%. A study by the UCH team from London headed by Professor S.J. Machin identified new measurements stemming from the reticulocyte channel of the XE-2100. The new measurements are the mean value of the forward light scatter histograms of mature red blood cells (RBC-Y) and of reticulocytes (RET-Y). The primary purpose of the study was to determine if these parameters correlated with CHr and % Hypo from the Bayer Advia in detecting functional iron deficiency in chronic renal failure. Despite the CHr being a measurement of mean reticulocyte haemoglobin content and RET-Y a measurement of reticulocyte size, the correlation between CHR and RET-Y in all patient groups was excellent and effectively interchangeable for clinical diagnostic purposes. There also existed reasonably good correlation between RBC-Y and % Hypo. While promising, further multicentre studies are required to assess the clinical utility of these new parameters and to demonstrate their correction with intravenous iron therapy. Automated quantitative analysis of bone marrow cellular composition [4] has proved difficult because of the heterogeneity of cell types, the identification of very small populations of abnormal cells and the contamination by fat particles. Dr. Gina Zini from the Universita Cattolica, Rome, describes her experience with the XE-2100 automated blood cell counter in bone marrow analysis. Automated analysis permits a valuable objective preliminary evaluation of marrow specimens prior to microscopy. Although a number of problems persist, the morphologist gains an immediate general perception of the quality and overall characteristics of the marrow, the total cellularity, the myeloid erythroid ratio, the presence and characteristics of abnormal cell clusters and the relative proportions of cells to fat. The final symposium papers in this issue are devoted to information technology and communication. Dr. R.M. Rowan, Glasgow, UK, reviews the current position of knowledgebased systems (KBS) [5] in the clinical laboratory, indicating their need but outlining objections to such systems which continue to come from the laboratory community. An overview of the architecture of KBS is presented, stressing the need for system transparency to gain user confidence. Mr. T. Schumacher of Sysmex Molis, Liege, Belgium describes an expert system shell, the Java-Medical Doctor (J-MD) which is a direct successor to the well-known PRO-MD shell [6] developed by the team led by Professor C. Trendelenburg, Städtische Kliniken, Frankfurt/M. The same team has re-developed the system using the 'state of the art' Java programming language. The main problems to be solved in creating this new system were maintainability of the knowledge base, integration into modern networks and improvement of end-user acceptance of computer-based decision support. The methods adopted to solve these problems are described. The advantages of this new system are three-fold: i) medical experts are able to formulate their knowledge without the assistance of knowledge engineers, ii) this communication concept makes knowledge readily accessible from laboratory information systems and from the outside world, and iii) the system is multi-disciplinary. Finally Professor P. Sinha from the Universitätsklinikum Charité, Berlin, reviews the need for storage and communication of the multiplicity of data both numerical and graphical, emanating from patients with chronic haematological disease. He describes the linking together of various analysers by means of a proprietary PC-based data processing system (PC-DPS) to form a comprehensive intelligent platform which is capable of streamlining laboratory workflow. Such a system provides real-time data and delta check, centralised quality control, reflex testing, reduction of interfaces to the LIS, online-help functions and, above all, completely user-defined rules. A further component consisting of a microscope, a CCD camera and PC-based software that can be coupled to the PC-DPS system enables personnel to develop tele-haematology (transmission of live morphology images directly from the microscope) routinely in the laboratory and beyond, thus permitting remote consultation (tele-conferencing). It can be upgraded by the addition of scanners to store additional clinical documents and images, can be connected to clinical units by means of a web server and can be used to communicate all this information by e-mail. There has been much change in the practice of routine diagnostic laboratory haematology since the days of Tallqvist (1900) and Sahli (1931) and even from the days of Crosland-Taylor (1953) and Coulter (1956) . This change continues to occur exponentially. The papers included in this issue give indications of the directions of change in terms of new parameters, implementation of information technology to assist in clinical decision making by expert systems and the use of modern communication systems. We live in exciting times.
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